Gingival Depigmentation Using Diode Laser 940nm Versus 980nm
NCT ID: NCT06167148
Last Updated: 2023-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2021-10-01
2023-11-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
940nm wavelength Diode laser
Biolase Epic X 940nm wavelength Diode laser
Participants were treated with Biolase Epic X 940nm wavelength Diode laser set at a power of 1 W, fiber 400 µ, irradiation mode: pulsed wave (P3).
980nm wavelength Diode laser
Doctor smile simpler 980nm wavelength Diode laser
Participants were treated with doctor smile simpler 980nm wavelength Diode laser set at a power of 1 W, fiber 400 µ, irradiation mode: pulsed wave (SP).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biolase Epic X 940nm wavelength Diode laser
Participants were treated with Biolase Epic X 940nm wavelength Diode laser set at a power of 1 W, fiber 400 µ, irradiation mode: pulsed wave (P3).
Doctor smile simpler 980nm wavelength Diode laser
Participants were treated with doctor smile simpler 980nm wavelength Diode laser set at a power of 1 W, fiber 400 µ, irradiation mode: pulsed wave (SP).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pigmentation extending from canine to canine in either upper or lower arch.
Exclusion Criteria
* Patients with uncontrolled metabolic disease.
* Immuno-compromised patients.
* Patients with renal disease.
* Patients having coagulation disorders.
* Pregnant and lactating women.
* Evidence about the relation of pigmentation with malignancies.
* History of previous treatment of gingival pigmentation.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nourhan M.Aly
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nourhan M.Aly
Assistant Lecturer of Dental Public Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Souzy K Anwar, PhD
Role: PRINCIPAL_INVESTIGATOR
Alexandria University
Yasmine Y Gaweesh, PhD
Role: STUDY_DIRECTOR
Alexandria University
Nourhan M Aly, MSc
Role: STUDY_DIRECTOR
Alexandria University
Gillan I El-Kimary, PhD
Role: STUDY_CHAIR
Alexandria University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Dentistry, Alexandria University
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5/23
Identifier Type: -
Identifier Source: org_study_id